Patents by Inventor Panpan Kang

Panpan Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GLUCOPYRANOSYL DERIVATIVES AND THEIR USES
    Publication number: 20230086354
    Abstract: At present relates to a glucopyranosyl derivative and application thereof. In particular, relates to a glucopyranosyl derivative as a sodium-dependent glucose transporters1 (SGLT1) inhibitor, and a pharmaceutically acceptable salt or a stereoisomer thereof, and further relates to a pharmaceutical composition containing the derivative.
    Type: Application
    Filed: July 9, 2020
    Publication date: March 23, 2023
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng GU, Wuyong WU, Panpan KANG, Weihua WANG, Jianyu LIU, Xinshan DENG
  • Glucopyranosyl derivative and use thereof
    Patent number: 11186602
    Abstract: A glucopyranosyl derivative is used as an inhibitor of sodium-dependent glucose transporters (SGLTs), particularly being used as an inhibitor of sodium-dependent glucose transporter-1 (SGLT1), and a pharmaceutically acceptable salt or stereoisomer thereof, further relating to a pharmaceutical composition containing the derivative. The compound and a pharmaceutical composition is used thereof in the preparation of a drug for treating diabetes and diabetes-related diseases.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: November 30, 2021
    Assignee: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng Gu, Wuyong Wu, Panpan Kang, Tong Qu, Zongyuan Zhang, Weiming Huang, Tianyun Wu, Yingjun Zhang
  • Glucopyranosyl derivative and use thereof
    Patent number: 11084842
    Abstract: A glucopyranosyl derivative as a sodium-dependent glucose transporters inhibitor, especially as a SGLT1 inhibitor, a pharmaceutically acceptable salt or a stereoisomer thereof, a pharmaceutical composition thereof, and the uses of the compound and pharmaceutical composition thereof in the preparation of drugs for the treatment of diabetes and diabetes-related diseases.
    Type: Grant
    Filed: January 22, 2019
    Date of Patent: August 10, 2021
    Assignee: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng Gu, Wuyong Wu, Tong Qu, Panpan Kang, Zongyuan Zhang, Weiming Huang, Jianyu Liu, Yingjun Zhang
  • GLUCOPYRANOSYL DERIVATIVE AND USE THEREOF
    Publication number: 20210061839
    Abstract: A glucopyranosyl derivative as a sodium-dependent glucose transporters inhibitor, especially as a SGLT1 inhibitor, a pharmaceutically acceptable salt or a stereoisomer thereof, a pharmaceutical composition thereof, and the uses of the compound and pharmaceutical composition thereof in the preparation of drugs for the treatment of diabetes and diabetes-related diseases.
    Type: Application
    Filed: January 22, 2019
    Publication date: March 4, 2021
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng GU, Wuyong WU, Tong QU, Panpan KANG, Zongyuan ZHANG, Weiming HUANG, Jianyu LIU, Yingjun ZHANG
  • GLUCOPYRANOSYL DERIVATIVE AND USE THEREOF
    Publication number: 20210054013
    Abstract: A glucopyranosyl derivative is used as an inhibitor of sodium-dependent glucose transporters (SGLTs), particularly being used as an inhibitor of sodium-dependent glucose transporter-1 (SGLT1), and a pharmaceutically acceptable salt or stereoisomer thereof, further relating to a pharmaceutical composition containing the derivative. The compound and a pharmaceutical composition is used thereof in the preparation of a drug for treating diabetes and diabetes-related diseases.
    Type: Application
    Filed: January 29, 2019
    Publication date: February 25, 2021
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng GU, Wuyong WU, Panpan KANG, Tong QU, Zongyuan ZHANG, Weiming HUANG, Tianyun WU, Yingjun ZHANG
  • Complex of a glucopyranosyl derivative and preparation method and use thereof
    Patent number: 10555930
    Abstract: This present invention relates to a complex of a glucopyranosyl derivative and L-pyroglutamic acid as a sodium dependent glucose cotransporter (SGLT) inhibitor, and preparation processes thereof, and a pharmaceutical composition containing the complex, and their uses in the manufacture of a medicament for treating diabetes and/or diabetes-related diseases.
    Type: Grant
    Filed: November 28, 2016
    Date of Patent: February 11, 2020
    Assignee: NORTH & SOUTH BROTHER PHARMACY INVESTMENT COMPANY LIMITED
    Inventors: Pengcho Tang, Zheng Gu, Wuyong Wu, Zongyuan Zhang, Panpan Kang, Tong Qu
  • COMPLEX OF A GLUCOPYRANOSYL DERIVATIVE AND PREPARATION METHOD AND USE THEREOF
    Publication number: 20180344689
    Abstract: This present invention relates to a complex of a glucopyranosyl derivative and L-pyroglutamic acid as a sodium dependent glucose cotransporter (SGLT) inhibitor, and preparation processes thereof, and a pharmaceutical composition containing the complex, and their uses in the manufacture of a medicament for treating diabetes and/or diabetes-related diseases.
    Type: Application
    Filed: November 28, 2016
    Publication date: December 6, 2018
    Applicant: Sunshine Lake Pharma Co., Ltd.
    Inventors: Pengcho TANG, Zheng GU, Wuyong WU, Zongyuan ZHANG, Panpan KANG, Tong QU
  • Hexahydropentaleno derivatives, preparation method and use in medicine thereof
    Patent number: 9567300
    Abstract: The invention relates to hexahydropentaleno derivatives, the preparation method and use in medicine thereof, and in particular to hexahydropentaleno derivatives or stereo-isomers or pharmaceutically acceptable salts thereof as shown in general formula (I), and to the preparation method therefor and pharmaceutical compositions comprising the derivatives, and to the use thereof as a therapeutical agent, especially as a DPP-IV inhibitor. The definition of each substituent in formula (I) is the same as the definition in the description.
    Type: Grant
    Filed: June 25, 2013
    Date of Patent: February 14, 2017
    Assignee: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng Gu, Guanpeng Qiu, Wuyong Wu, Panpan Kang, Zongyuan Zhang, Gang Chen, Chengsheng Lan, Yonggang Wei, Jiaping Wen, Guozhi Zhu, Yonghua Lu, Heran Wang, Yincai Wang, Mingyun Yuan, Kangzhi Ye, Guizhuan Su, PengCho Tang
  • Glucopyranosyl derivatives and their uses in medicine
    Patent number: 9394329
    Abstract: Disclosed are glucopyranosyl derivatives used as sodium dependent glucose cotransporters (SGLTs) inhibitors, intermediates or preparation processes thereof, and pharmaceutical uses thereof, especially glucopyranosyl derivatives represented by Formula (I), or pharmaceutically acceptable salts or all stereoisomers thereof, pharmaceutical compositions containing these derivatives and their uses for treatment of diabetes and diabetes-related diseases.
    Type: Grant
    Filed: September 26, 2014
    Date of Patent: July 19, 2016
    Assignee: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Yonggang Wei, Jiaping Wen, Guozhi Zhu, Yonghua Lu, Heran Wang, Yincai Wang, Mingyun Yuan, Zheng Gu, Wuyong Wu, Panpan Kang, Zongyuan Zhang, Gang Chen, Pengcho Tang
  • HEXAHYDROPENTALENO DERIVATIVES, PREPARATION METHOD AND USE IN MEDICINE THEREOF
    Publication number: 20150299118
    Abstract: The invention relates to hexahydropentaleno derivatives, the preparation method and use in medicine thereof, and in particular to hexahydropentaleno derivatives or stereo-isomers or pharmaceutically acceptable salts thereof as shown in general formula (I), and to the preparation method therefor and pharmaceutical compositions comprising the derivatives, and to the use thereof as a therapeutical agent, especially as a DPP-IV inhibitor. The definition of each substituent in formula (I) is the same as the definition in the description.
    Type: Application
    Filed: June 25, 2013
    Publication date: October 22, 2015
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng Gu, Guanpeng Qiu, Wuyong Wu, Panpan Kang, Zongyuan Zhang, Gang Chen, Chengsheng Lan, Yonggang Wei, Jiaping Wen, Guozhi Zhu, Yonghua Lu, Heran Wang, Yincai Wang, Mingyun Yuan, Kangzhi Ye, Guizhuan Su, PengCho Tang
  • GLUCOPYRANOSYL DERIVATIVES AND THEIR USES IN MEDICINE
    Publication number: 20150266916
    Abstract: Disclosed are glucopyranosyl derivatives used as sodium dependent glucose cotransporters (SGLTs) inhibitors, intermediates or preparation processes thereof, and pharmaceutical uses thereof, especially glucopyranosyl derivatives represented by Formula (I), or pharmaceutically acceptable salts or all stereoisomers thereof, pharmaceutical compositions containing these derivatives and their uses for treatment of diabetes and diabetes-related diseases.
    Type: Application
    Filed: September 26, 2014
    Publication date: September 24, 2015
    Applicant: Sunshine Lake Pharma Co., Ltd.
    Inventors: Yonggang Wei, Jiaping Wen, Guozhi Zhu, Yonghua Lu, Heran Wang, Yincai Wang, Mingyun Yuan, Zheng Gu, Wuyong Wu, Panpan Kang, Zongyuan Zhang, Gang Chen, Pengcho Tang